Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meyer-Haake is a privately held German medical technology company that develops and manufactures physician-focused products for surgery, wound closure, dermatology, cosmetic medicine, and related clinical specialties. Founded in 1981, the company initially served dentistry and later expanded into proprietary medical devices and tissue adhesives manufactured in Germany. Its marketed portfolio includes the EPIGLU tissue adhesive line, the radioSURG 2200 radiosurgery systems, smokeSTAR smoke evacuation products, and RF-ReFacing aesthetic equipment. The business appears to be a commercial-stage medtech manufacturer rather than a drug-development biotech company, with global distribution and a focus on practical products for ambulatory and specialist procedural settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meyer-Haake.